Advanced search
Publication Cover
Postgraduate Medicine Volume 132, 2020 - Issue sup2: Supplement: Introducing oral semaglutide and the PIONEER program to primary care
Submit an article Journal homepage
4,170
Views
8
CrossRef citations to date
0
Altmetric
Supplement: introducing oral semaglutide and the PIONEER program to primary care

Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes compared with other oral antihyperglycemic agents and placebo

Frank Laverniaa North Broward Diabetes Center, Pompano Beach, FL, USACorrespondence[email protected]
View further author information
&
Lawrence Blondeb Department of Endocrinology, Ochsner Medical Center, New Orleans, LA, USAORCID Iconhttps://orcid.org/0000-0003-0492-6698View further author information
ORCID Icon
Pages 15-25 | Received 01 Jun 2020, Accepted 17 Jul 2020, Published online: 08 Sep 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.